EMD Lexigen Research Center Corp.
Records under this name other than patents EMD Lexigen Research Center Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to EMD Lexigen Research Center Corp.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,767,405 | Immunocytokine Sequences and Uses Thereof Formerly held Term ended Term ended Nov 30, 2025 · High confidence | Term ended | Term ended Nov 30, 2025 | High confidence |
| US 8,420,087 | INTERLEUKIN-12 Targeted to Oncofoetal Fibronectin Formerly held Lapsed on the fee record Ended Apr 16, 2025 · High confidence | Lapsed on the fee record | Ended Apr 16, 2025 | High confidence |
| US 7,186,804 | IL-2 Fusion Proteins with Modulated Selectivity Formerly held Term ended Term ended Jan 20, 2025 · High confidence | Term ended | Term ended Jan 20, 2025 | High confidence |
| US 7,323,549 | IL-7 Fusion Proteins Formerly held Term ended Term ended Dec 30, 2024 · High confidence | Term ended | Term ended Dec 30, 2024 | High confidence |
| US 8,338,575 | IL-7 Fusion Proteins Formerly held Lapsed on the fee record Ended Dec 25, 2024 · High confidence | Lapsed on the fee record | Ended Dec 25, 2024 | High confidence |
| US 8,470,991 | Immunocytokine Sequences and Uses Thereof Formerly held Term ended Term ended May 21, 2024 · High confidence | Term ended | Term ended May 21, 2024 | High confidence |
| US 7,169,904 | Immunocytokine Sequences and Uses Thereof Formerly held Term ended Term ended Dec 16, 2023 · High confidence | Term ended | Term ended Dec 16, 2023 | High confidence |
| US 7,960,514 | IL-7 Fusion Proteins Formerly held Lapsed on the fee record Ended Jun 14, 2023 · Medium confidence | Lapsed on the fee record | Ended Jun 14, 2023 | Medium confidence |
| US 7,888,071 | DNA Encoding IL-2 Fusion Proteins with Modulated Selectivity Formerly held Lapsed on the fee record Ended Feb 15, 2023 · Medium confidence | Lapsed on the fee record | Ended Feb 15, 2023 | Medium confidence |
| US 6,992,174 | Reducing the Immunogenicity of Fusion Proteins Formerly held Term ended Term ended Jan 28, 2023 · High confidence | Term ended | Term ended Jan 28, 2023 | High confidence |